Rampart Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-9,102
Closed -$348K 51
2020
Q3
$348K Sell
9,102
-17,005
-65% -$655K 0.22% 109
2020
Q2
$917K Buy
26,107
+13,958
+115% +$503K 0.15% 176
2020
Q1
$396K Sell
12,149
-12,082
-50% -$472K 0.19% 114
2019
Q4
$1.1M Sell
24,231
-237
-1% -$9.92K 0.13% 209
2019
Q3
$996K Sell
24,468
-1,386
-5% -$58.7K 0.12% 218
2019
Q2
$1.11M Sell
25,854
-1,832
-7% -$70.5K 0.13% 208
2019
Q1
$1.06M Buy
27,686
+12,778
+86% +$488K 0.12% 224
2018
Q4
$527K Sell
14,908
-17,917
-55% -$650K 0.15% 140
2018
Q3
$590K Sell
32,825
-6,611
-17% -$231K 0.26% 97
2018
Q2
$1.29M Sell
39,436
-16,384
-29% -$494K 0.13% 228
2018
Q1
$1.52M Buy
55,820
+38,950
+231% +$1.06M 0.15% 196
2017
Q4
$418K Sell
16,870
-1,847
-10% -$50.9K 0.16% 155
2017
Q3
$546K Buy
18,717
+1,048
+6% +$28.9K 0.18% 127
2017
Q2
$490K Buy
17,669
+13,967
+377% +$371K 0.18% 132
2017
Q1
$92K Buy
+3,702
New +$90K 0.03% 156

Other funds holding BSX

Rampart Investment Management's BSX Position: Q4 2020 in Review

Rampart Investment Management sold out of Boston Scientific (BSX) in Q4 2020, closing a stake of 9,102 shares — an estimated $348K sold.

Rampart Investment Management first reported a position in BSX in Q1 2017 and held it in 15 quarters. The position peaked at $1.52M in Q1 2018. 864 funds tracked by Wall St. Rank hold BSX as of Q4 2020.

  • Rampart Investment Management reported no remaining Boston Scientific position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 9,102 Boston Scientific shares in Q4 2020, an estimated $348K.
  • Rampart Investment Management first reported a position in Boston Scientific in Q1 2017 and held it in 15 quarters.
  • Rampart Investment Management's Boston Scientific position peaked at $1.52M in Q1 2018.
  • 864 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.